Insulin detemir Subcutaneous and Loteprednol and tobramycin ophthalmic
Determining the interaction of Insulin detemir Subcutaneous and Loteprednol and tobramycin ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Loteprednol Etabonate
- Insulin detemir Subcutaneous-Loteprednol Eye Drops
- Insulin detemir Subcutaneous-Loteprednol Eye Drops 0.2%
- Insulin detemir Subcutaneous-Loteprednol Eye Drops 0.5% and 1%
- Insulin detemir Subcutaneous-Loteprednol Eye Gel
- Insulin detemir Subcutaneous-Loteprednol Eye Ointment
- Loteprednol and tobramycin ophthalmic-Insulin glargine
- Loteprednol and tobramycin ophthalmic-Insulin Glargine (U-100) Cartridge Systems and Pens
- Loteprednol and tobramycin ophthalmic-Insulin Glargine (U-100) Vials
- Loteprednol and tobramycin ophthalmic-Insulin Glargine (U-300) Pens
- Loteprednol and tobramycin ophthalmic-Insulin glargine and lixisenatide
- Loteprednol and tobramycin ophthalmic-Insulin glargine and lixisenatide Subcutaneous